[1]于 东.平消片为主组合方案治疗乳腺增生症临床分析[J].医学信息,2018,31(08):136-137.[doi:10.3969/j.issn.1006-1959.2018.08.046]
　YU Dong.Clinical Analysis of the Combination of Pingxiao Tablets in the Treatment of Mammary Hyperplasia[J].Journal of Medical Information,2018,31(08):136-137.[doi:10.3969/j.issn.1006-1959.2018.08.046]
点击复制

平消片为主组合方案治疗乳腺增生症临床分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
136-137
栏目:
药物与临床
出版日期:
2018-04-15

文章信息/Info

Title:
Clinical Analysis of the Combination of Pingxiao Tablets in the Treatment of Mammary Hyperplasia
文章编号:
1006-1959（2018）08-0136-02
作者:
于 东
瓦房店中医医院外科，辽宁 瓦房店 116300
Author(s):
YU Dong
Department of Surgery,Wafangdian Traditional Chinese Medicine Hospital,Wafangdian 116300,Liaoning,China
关键词:
平消片; 三苯氧胺; 托瑞米芬; 乳腺增生症
Keywords:
Key words:Pingxiao tablet; Tamoxifen; Tolemiphene; Mammary hyperplasia
分类号:
R271.44
DOI:
10.3969/j.issn.1006-1959.2018.08.046
文献标志码:
A
摘要:
目的 分析平消片为主组合方案治疗乳腺增生症的临床疗效。方法 选取我院2015年1月~2016年12月100例乳腺增生症患者作为观察对象，随机分为观察组和对照组，每组50例。对照组采用三苯氧胺联合平消片的治疗方案；观察组采用托瑞米芬联合平消片的治疗方案。比较两组患者的临床疗效以及不良反应发生率。结果 观察组与对照组的治疗有效率分别为92.00%和90.00%，两组相比，差异无统计学意义（P＞0.05）。观察组不良反应发生率为6.00%，低于对照组的22.00%，差异具有统计学意义（P＜0.05）。结论 三苯氧胺联合平消片与托瑞米芬联合平消片在乳腺增生症的临床治疗中均有较好的临床疗效，但托瑞米芬联合平消片的安全性更高，值得在临床中推广使用。
Abstract:
Abstract：Objective To analyze the clinical effect of Pingxiao tablet combined regimen in the treatment of mammary hyperplasia. Methods 100 patients with breast hyperplasia from January 2015 to December 2016 were randomly divided into observation group and control group with 50 cases in each group.The control group was treated with tamoxifen combined with Pingxiao tablet and the observation group with tolemiphene combined with pingxiao tablet.The clinical efficacy and incidence of adverse reactions were compared between the two groups.Results The effective rates of treatment were 92.00% and 90.00% in the observation group and the control group,respectively,there was no significant difference between the two groups(P>0.05).The incidence of adverse reactions in the observation group was 6.00%,which was lower than that in the control group 22.00%,and the difference was statistically significant(P <0.05).Conclusion The combination of tamoxifen and torreifene in the clinical treatment of hyperplasia of mammary glands has good clinical effect,but the safety of toromifene combined with Ping Xiao tablet is higher.It is worth popularizing in clinical practice.

参考文献/References:

[1]李伟东,刘朝霞,杨德林,等.三苯氧胺联合平消片治疗乳腺增生症效果观察[J].河北医药,2013,34(17):2618-2619.
[2]熊莉.托瑞米芬联合平消片治疗乳腺增生症的临床研究[J].吉林医学,2015,32(11):2094-2095.
[3]魏东新,齐荣国,王清源,等.平消片联合托瑞米芬治疗乳腺增生症疗效观察[J].中国医药,2015,06(7):832-833.
[4]高学忠,董树枫,周瑛,等.平消片为主组合方案治疗乳腺增生症临床分析[J].浙江中西医结合杂志,2014,14(2):87-88.
[5]高学忠,董树枫.平消片为主组合方案治疗乳腺增生症临床研究[J].肿瘤研究与临床,2015,15(5):347-348.
[6]邱冬梅.平消片联合维生素E治疗乳腺增生180例疗效观察[J].中国现代医生,2014,47(13):98-99.
[7]付立晶,金恒善,焦鹏涛等.乳癖消片联合桂枝茯苓胶囊治疗乳腺增生症的临床效果观察[J].河北医学,2016,12(6):536-537.

相似文献/References:

[1]李 焰,何 山,郑 轲,等.化疗后续用三苯氧胺对乳腺癌患者激素水平的影响[J].医学信息,2019,32(20):133.[doi:10.3969/j.issn.1006-1959.2019.20.041]
　LI Yan,HE Shan,ZHENG Ke,et al.Effect of Chemotherapy Followed by Tamoxifen on Hormone Levels in Patients with Breast Cancer[J].Journal of Medical Information,2019,32(08):133.[doi:10.3969/j.issn.1006-1959.2019.20.041]

更新日期/Last Update: 2018-04-15